# Constellation Pharmaceuticals, Inc. (CNST)

Source: https://www.quantisnow.com/company/CNST
Generated: 2026-11-22T04:54:38.502Z

- Ticker: CNST
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2018

## Latest CNST news and filings

- 2021-07-26 10:04 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-constellation-pharmaceuticals-inc-1486743)
- 2021-07-23 20:27 UTC [SEC Form 4] [SEC Form 4 filed by Hoerter Steven L. (Amendment)](https://www.quantisnow.com/insight/sec-form-4-filed-by-hoerter-steven-l-amendment-1481143)
- 2021-07-19 22:45 UTC [SEC Form 4] [SEC Form 4 filed by Humphrey Jeffrey](https://www.quantisnow.com/insight/sec-form-4-filed-by-humphrey-jeffrey-1421370)
- 2021-07-19 21:40 UTC [SEC Form 4] [SEC Form 4 filed by Trojer Patrick](https://www.quantisnow.com/insight/sec-form-4-filed-by-trojer-patrick-1420966)
- 2021-07-19 21:40 UTC [SEC Form 4] [SEC Form 4 filed by Trehu Elizabeth](https://www.quantisnow.com/insight/sec-form-4-filed-by-trehu-elizabeth-1420965)
- 2021-07-19 21:41 UTC [SEC Form 4] [SEC Form 4 filed by Valentine Karen](https://www.quantisnow.com/insight/sec-form-4-filed-by-valentine-karen-1420964)
- 2021-07-19 21:37 UTC [SEC Form 4] [SEC Form 4: Raythatha Jigar returned 14,961 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-raythatha-jigar-returned-14961-units-of-common-1420945)
- 2021-07-19 21:38 UTC [SEC Form 4] [SEC Form 4 filed by Reeve Emma](https://www.quantisnow.com/insight/sec-form-4-filed-by-reeve-emma-1420944)
- 2021-07-19 21:35 UTC [SEC Form 4] [SEC Form 4 filed by Hoerter Steven L.](https://www.quantisnow.com/insight/sec-form-4-filed-by-hoerter-steven-l-1420908)
- 2021-07-19 21:33 UTC [SEC Form 4] [SEC Form 4 filed by Braunstein Scott](https://www.quantisnow.com/insight/sec-form-4-filed-by-braunstein-scott-1420844)
- 2021-07-19 21:34 UTC [SEC Form 4] [SEC Form 4: GOLDSMITH MARK A returned 89,857 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-goldsmith-mark-a-returned-89857-units-of-1420843)
- 2021-07-19 21:27 UTC [SEC Form 4] [SEC Form 4 filed by Levy Richard S](https://www.quantisnow.com/insight/sec-form-4-filed-by-levy-richard-s-1420804)
- 2021-07-19 21:29 UTC [SEC Form 4] [SEC Form 4: Audia James E returned 25,434 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-audia-james-e-returned-25434-units-of-1420801)
- 2021-07-19 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-constellation-pharmaceuticals-inc-1407180)
- 2021-07-15 14:34 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-constellation-pharmaceuticals-inc-1378603)
- 2021-07-15 14:35 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-constellation-pharmaceuticals-inc-1378602)
- 2021-07-15 14:35 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-constellation-pharmaceuticals-inc-1378601)
- 2021-07-15 14:37 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-constellation-pharmaceuticals-inc-1378600)
- 2021-07-15 14:33 UTC [SEC Form POSASR filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-constellation-pharmaceuticals-inc-1378485)
- 2021-07-15 14:32 UTC [SEC Form POSASR filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-constellation-pharmaceuticals-inc-1378455)
- 2021-07-15 14:30 UTC [SEC Form POS AM filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-constellation-pharmaceuticals-inc-1378440)
- 2021-07-15 13:40 UTC [SEC Form 8-K] [Constellation Pharmaceuticals, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/constellation-pharmaceuticals-inc-filed-sec-form-8-k-completion-of-acquisition-1377153)
- 2021-07-15 13:14 UTC [SEC Form 25-NSE filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-constellation-pharmaceuticals-inc-1376593)
- 2021-07-15 12:47 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-constellation-pharmaceuticals-inc-amendment-1375753)
- 2021-07-15 12:45 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-constellation-pharmaceuticals-inc-amendment-1375722)
- 2021-07-15 06:20 UTC [MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology](https://www.quantisnow.com/insight/morphosys-to-complete-transformational-acquisition-of-constellation-pharmaceuticals-bolstering-its-1371781)
- 2021-07-06 20:16 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-constellation-pharmaceuticals-inc-amendment-1267477)
- 2021-07-06 20:11 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-constellation-pharmaceuticals-inc-amendment-1267241)
- 2021-07-01 20:50 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-constellation-pharmaceuticals-inc-amendment-1228501)
- 2021-07-01 20:11 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-constellation-pharmaceuticals-inc-amendment-1227047)
- 2021-07-01 14:45 UTC [MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals](https://www.quantisnow.com/insight/morphosys-announces-expiration-of-the-hart-scott-rodino-waiting-period-for-acquisition-1220933)
- 2021-07-01 12:01 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-constellation-pharmaceuticals-inc-amendment-1217654)
- 2021-07-01 12:01 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Constellation Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-constellation-pharmaceuticals-inc-amendment-1217653)
- 2021-06-17 11:09 UTC [Analyst Downgrade] [Constellation Pharmaceuticals downgraded by RBC Capital Mkts with a new price target](https://www.quantisnow.com/insight/constellation-pharmaceuticals-downgraded-by-rbc-capital-mkts-with-a-new-1047141)
- 2021-06-16 21:20 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-constellation-pharmaceuticals-inc-1042051)
- 2021-06-16 20:52 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-constellation-pharmaceuticals-inc-1041145)
- 2021-06-11 13:00 UTC [Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib](https://www.quantisnow.com/insight/constellation-pharmaceuticals-provides-an-update-from-the-ongoing-manifest-study-984307)
- 2021-06-04 23:15 UTC [SEC Form 4] [SEC Form 4 filed by Levy Richard S](https://www.quantisnow.com/insight/sec-form-4-filed-by-levy-richard-s-963891)
- 2021-06-04 21:47 UTC [SEC Form 4] [SEC Form 4 filed by Constellation Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-constellation-pharmaceuticals-inc-963704)
- 2021-06-04 21:46 UTC [SEC Form 4] [SEC Form 4 filed by GOLDSMITH MARK A](https://www.quantisnow.com/insight/sec-form-4-filed-by-goldsmith-mark-a-963702)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CNST
- Earnings history: https://www.quantisnow.com/earnings/CNST
- Dividend history: https://www.quantisnow.com/dividends/CNST
- Insider transactions: https://www.quantisnow.com/insiders/CNST
- Options chain: https://www.quantisnow.com/options/CNST
- SEC 8-K filings only: https://www.quantisnow.com/company/CNST/8-k
- RSS and alerts for CNST: https://www.quantisnow.com/docs/rss-feeds.md
